RGCIRC hosts Breast Cancer Update Conference 2024

New Delhi: The Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) successfully hosted the “Breast Cancer Update Conference 2024” on June 15th and 16th. This significant event brought together leading experts, researchers, healthcare professionals, and faculty from India and abroad to explore the latest breakthroughs in breast cancer research and treatment.

Held under the patronship of Chairman Rakesh Chopra, the two-day conference highlighted critical findings from prominent global forums such as the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), and the San Antonio Breast Cancer Symposium (SABCS). The event featured expert-led sessions on emerging therapies, precision medicine, and patient-centred care, alongside panel discussions and interactive workshops designed to foster knowledge exchange and collaboration.

Key topics included early-stage breast cancer, metastatic breast cancer, triple-negative breast cancer, and advanced treatment options such as immunotherapy and precision medicine. Renowned oncologists presented significant findings from recent studies and the latest trials on targeted therapies, including Pembrolizumab, cyclin inhibitor tablets, and innovative surgical procedures and radiation techniques that are revolutionizing breast cancer management.

Dr. D C Doval, Chair of Medical Oncology & Chief of Breast & Thoracic Services at RGCIRC, emphasized, “The Breast Cancer Update Conference 2024 provided an invaluable opportunity for professionals to learn from each other and stay abreast of the latest research and clinical practices worldwide. Our goal is to advance our collective efforts in breast cancer care and improve patient outcomes. Together, we can make significant strides in the fight against breast cancer.”

Dr. Pankaj Goyal, Senior Consultant, Medical Oncology at RGCIRC, highlighted, “Our goal is to ensure that the latest advancements in breast cancer research are rapidly translated into clinical practice. This conference has been instrumental in bridging the gap between research and patient care, and we are committed to continuing this momentum.”

Interactive panel discussions allowed for robust exchanges of ideas and experiences among top oncologists, researchers, and clinicians. These panels covered critical subjects such as high-risk breast cancer, metastatic breast cancer, and the evolving role of immunotherapy in treatment protocols.

Dr. (Prof) Sudhir Kumar Rawal, Medical Director at RGCIRC, highlighted the conference’s role in bridging the gap between research and patient care. Dr. Vineet Talwar, Director of Medical Oncology, expressed optimism about the impact of the conference, while Dr. A.K. Dewan, Director of Surgical Oncology, emphasized RGCIRC’s ongoing commitment to addressing the complexities of breast cancer.